Studies have shown that SLC7A11 plays a crucial role in the biology of breast tumor stem cells, leading to the design of various anti-SLC7A11 vaccine formulations, including DNA plasmid vaccines, virus-like particles (VLP), and bovine herpesvirus type 4 (BoHV-4) vaccines (Ruiu et al., 2019). Here, SLC7A11 is linked to breast neoplasm.